Bullous systemic lupus erythematosus (BSLE) is a rare and severe form of cutaneous lupus erythematosus that presents with blistering lesions. It is a manifestation of systemic lupus erythematosus ...

Jan. 21, 2025 — Researchers identified a key protein as a potential therapeutic target for stopping the body's immune system from mistakenly attacking itself, offering new hope for treating ...

Autoimmune bullous diseases are a group of disorders characterized by the formation of blisters on the skin and mucous membranes due to an abnormal immune response. These diseases occur when the ...

However, for the vast majority of lupus flares the initial treatment has to be systemic glucocorticoids. For most manifestations, prednisone at 0.25–0.5 mg/kg body weight (or equivalent ...

Biomarkers that reliably identify or even predict disease manifestations in systemic lupus erythematosus (SLE) are needed. In a recent issue of the Clinical Journal of the American Society of ...

Atomi Financial Group Inc. bought a new stake in argenx SE (NASDAQ:ARGX – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange ...

SE (NASDAQ:ARGX – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty-two analysts that are ...

The less common bullous variety occurs in children younger than 2 years old in 90% of people with it. When impetigo does occur in adults, it’s more common in people assigned male at birth.